HUMA

Humacyte Inc
3.24
0.16 (5.19%)

Humacyte Inc. (HUMA) Fundamentals

Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries and chronic conditions.
SHARE INFORMATION
Market Cap$ 317,604,860
Shares Outstanding103,118,461
Float42,775,611
Percent Float41.48%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 0
Latest Fiscal EPS$ 1.95
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions169
Institutional Holdings Date2023-01-31
Institutional Bought Previous 3 Months1,734,249
Institutional Holdings Percent22.1%
Institutional Sold Previous 3 Months2,132,063
Insider Holdings Date2022-12-31
Insider Bought Previous 3 Months1,440,284
Insider Holdings Percent1.9
Insider Sold Previous 3 Months2,824,368
Insider Shares Owned1,931,997
TRADING INFO
52 Week High$ 8.04
52 Week Low$ 1.96
52 Week High Change$ -38.77
21 Day Moving Average$ 2.5448
21 Day Extended Moving Average$ 2.6259
50 Day Moving Average$ 2.6505
50 Day Extended Moving Average$ 2.7009
200 Day Moving Average$ 3.8046
200 Day Extended Moving Average$ 4.0424
10 Day Average Volume242,309
20 Day Average Volume231,870
30 Day Average Volume268,100
50 Day Average Volume370,192
Alpha-0.069129
Beta1.1397
Standard Deviation0.204931
R20.123535
7 Day Price Change$ 0.48
7 Day Percent Change18.46%
21 Day Price Change$ 0.59
21 Day Percent Change23.69%
30 Day Price Change$ 0.97
30 Day Percent Change45.97%
Month to Date Price Change$ 0.45
Month to Date Percent Change17.11%
Quarter to Date Price Change$ 0.97
Quarter to Date Percent Change45.97%
180 Day Price Change$ -0.30
180 Day Percent Change-8.88%
200 Day Price Change$ -0.42
200 Day Percent Change-12.0%
Year to Date Price Change$ 0.97
Year to Date Percent Change45.97%

Humacyte Inc. (HUMA) Key Ratios

PROFITABILITY
EBIT Margin0.0%
EBITDA Margin0.0%
Pre-Tax Profit Margin0.0%
Profit Margin Count0.0%
Gross Margin0.0%
Profit Margin TOT0.0%
INCOME STATEMENTS
Revenue$ 0
Revenue Per Share$ 0.00
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book2.50
Total Debt To Equity0.40
Int Coverage6.80
Current Ratio9.80
Leverage Ratio2.00
Quick Ratio9.60
Long Term Debt To Capital0.27
VALUATION MEASURES
PE Ratio1.00
Enterprise Value$ 177,173,352
Price to Sales0.00
Price to Free Cash-5.70
PE High Last 5 Years0.00
Price To Book2.50
Price To Cash Flow0.00
PE Low Last 5 Years0.00
Price to Tangible Book2.50
MANAGEMENT EFFECTIVENESS
Receivables Turnover0.00
Invoice Turnover0.00
Assets Turnover0.00
Return Assets12.97
Return on Equity35.31
Return on Capital25.85

Humacyte Inc. (HUMA) Profile

PROFILE INFO
Issue TypeCS
SEC Type-
AuditorPricewaterhouseCoopers LLP
CEOLaura E. Niklason
Emplyoees146
Last AuditUQ
CIK0001818382
IndustryBiotechnology
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address2525 East North Carolina Highway 54
Durham, NC 27713
Websitehttps://www.humacyte.com
Facsimile-
Telephone+1 919 313-9633
Email-


Your Recent History
NASDAQ
HUMA
Humacyte
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.